1 Woo PC, "Usefulness of the MicroSeq 500 16S ribosomal DNA-based bacterial identification system for identification of clinically significant bacterial isolates with ambiguous biochemical profiles" 41 : 1996-2001, 2003
2 Relman DA, "Universal bacterial 16S rRNA amplification and sequencing In: Diagnostic molecular microbiology priniciples and applications" ASM Press 489-495, 1993
3 Beaumont RJ, "Trimethoprim as a possible therapy for nocardiosis and melioidosis" 2 : 1123-1127, 1970
4 National Committee for Clinical Laboratory Standards (NCCLS), "Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes; Approved Standard" NCCLS 2003
5 Peleg AY, "Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study" 44 : 1307-1314, 2007
6 Agterof MJ, "Nocardiosis: a case series and a mini review of clinical and microbiological features" 65 : 199-202, 2007
7 Lerner PI, "Nocardiosis" 22 : 891-903, 1996
8 Simpson GL, "Nocardial infections in the immunocompromised host: A detailed study in a defined population" 3 : 492-507, 1981
9 Beaman BL, "Nocardial infections in the United States, 1972-1974" 134 : 286-289, 1976
10 Choucino C, "Nocardial infections in bone marrow transplant recipients" 23 : 1012-1019, 1996
1 Woo PC, "Usefulness of the MicroSeq 500 16S ribosomal DNA-based bacterial identification system for identification of clinically significant bacterial isolates with ambiguous biochemical profiles" 41 : 1996-2001, 2003
2 Relman DA, "Universal bacterial 16S rRNA amplification and sequencing In: Diagnostic molecular microbiology priniciples and applications" ASM Press 489-495, 1993
3 Beaumont RJ, "Trimethoprim as a possible therapy for nocardiosis and melioidosis" 2 : 1123-1127, 1970
4 National Committee for Clinical Laboratory Standards (NCCLS), "Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes; Approved Standard" NCCLS 2003
5 Peleg AY, "Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study" 44 : 1307-1314, 2007
6 Agterof MJ, "Nocardiosis: a case series and a mini review of clinical and microbiological features" 65 : 199-202, 2007
7 Lerner PI, "Nocardiosis" 22 : 891-903, 1996
8 Simpson GL, "Nocardial infections in the immunocompromised host: A detailed study in a defined population" 3 : 492-507, 1981
9 Beaman BL, "Nocardial infections in the United States, 1972-1974" 134 : 286-289, 1976
10 Choucino C, "Nocardial infections in bone marrow transplant recipients" 23 : 1012-1019, 1996
11 Yassin AF, "Nocardia elegans sp. nov., a member of the Nocardia vaccinii clade isolated from sputum" 55 : 1505-1509, 2005
12 Nolte FS, "Molecular detection and identification of microorgnisms In: Manual of clinical microbiology" ASM Press 218-, 2007
13 Watanabe K, "First clinical isolates of Nocardia carnea, Nocardia elegans, Nocardia paucivorans, Nocardia puris and Nocardia takedensis in Japan" 47 : 85-89, 2006
14 Wellinghausen N, "Expanded spectrum of Nocardia species causing clinical nocardiosis detected by molecular methods" 292 : 277-282, 2002
15 Munoz J, "Clinical and microbiological features of nocardiosis 1997-2003" 56 : 545-550, 2007
16 Goodfellow M, "Antibiotic sensitivity of some nocardioform bacteria and its value as a criterion for taxonomy" 83 : 375-387, 1974